Video & Transcript Research : 'patent'
Page 1 of 27
US
US Federal 2025-2026 Regular Session
Business meeting to consider S.527, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, S.1040, to amend the Federal Trade Commis Apr 3rd, 2025 at 09:15 am
Senate Judiciary
Transcript Highlights:
- You see patent practices and strengthen agency collaboration.
- PTO and the FDA to coordinate better on patents, we want to prevent companies from gaming the system
- through product hopping and patent thickets.
- Office for joint work on patent matters, including pharmaceutical patents.
- Next, S1097, Interagency Patent Coordination and Improvement Act of 2025.
Keywords:
drug competition, product hopping, generic drugs, biosimilars, federal regulations, FTC Act, patent, biological products, healthcare access, affordable prescriptions, Medicare, Federal Trade Commission, sham petitions, competition, public health, unfair competition, healthcare, pharmaceutical, antitrust law, pay-for-delay
Summary:
The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.
MN
Minnesota 2025-2026 Regular Session
House Higher Education Finance and Policy Committee 1/21/25
Higher Education Finance and Policy
Transcript Highlights:
- Who actually hones the patent?
- Who actually hones the patent?
- Who actually hones the patent?
- Who actually hones the patent?
- 48:42.599>
um <00:48:43.240>the 150 to 200 patents a year um the 150 to 200 patents a year
Summary:
The House Higher Education Finance and Policy Committee met and approved the minutes from the previous meeting. The chair noted that agency overviews from the Office of Higher Education and other state agencies were not available, so the committee proceeded with University of Minnesota presentations instead. The committee also reviewed posted committee rules.
University of Minnesota representatives gave an overview of the university’s research enterprise, describing it as a system of five campuses with a possible expansion to St. Cloud, and highlighting research strengths across campuses in agriculture, energy, natural resources, health, and the Twin Cities flagship campus. They said the university has more than $1.3 billion in annual research expenditures, receives most of its research funding from federal sources, and is ranked highly for both overall research and interdisciplinary research. Examples discussed included the Clinical and Translational Science Institute, the Forever Green initiative, and research tied to sustainable crops, health, and commercialization.
Members asked questions about specific research areas, including biodegradable or renewable plastics, wheat research, food dyes, health and environmental toxins, and the market for winter camelina and winter pennycress. University staff said they could follow up with more detailed information and explained that the winter crop work is intended to become market-driven over time, while also improving soil health and creating new revenue streams for farmers. They also clarified that the university’s federal research funding includes money from NIH, NSF, DOE, DOD, and other agencies, and that the “other” funding category includes foundations, subawards, and internal university seed funding.
The committee then heard a second University of Minnesota presentation focused on partnerships, commercialization, and workforce development. Testimony highlighted collaborations with industry and government partners such as U.S. Steel, 3M, Medtronic, Cisco, and defense-related industry leaders, as well as programs supporting microelectronics, AI, cybersecurity, and sustainable aviation fuels. No formal votes were taken beyond approving the minutes, and the committee ended the segment by moving on to the next testifier.
NM
New Mexico 2025 Regular Session
IC - Legislative Finance Jun 24th, 2025
Transcript Highlights:
- Are, uh, are you allowed in ownership of that patent since you developed it?
- that patent.
- Uh, to outside companies to develop that patent and NMSU is not exploring that.
- patented?
- develops that should be included in the patent in the development.
MN
Minnesota 2025-2026 Regular Session
Tax committee hears HF173 2/25/25
Transcript Highlights:
- Minnesota ranks first in medical device patents per capita, second in food patents per capita, and third
- in health patents, a testament to the innovation happening right here.
- Minnesota ranks first in medical device patents per capita, second in food patents per capita, and third
- Minnesota ranks first in medical device patents per capita, second in food patents per capita, and third
- Minnesota ranks first in medical device patents per capita, second in food patents per capita, and third
MN
Transcript Highlights:
- They have a patent on a model of how it's done.
- We have statute that guides the development of patents and copyrights, it's royalties, etc.
- And so, when there is a patent applied for or a new discovery made, they disclose that to us.
- Because, again, Water Quality 3D has their patent already.
- Water Quality 3D has their patent Water Quality 3D has their patent already.<00:50:31.760>
Uh
NM
New Mexico 2025 Regular Session
IC - Legislative Finance May 15th, 2025
Transcript Highlights:
- , come up with the technology and patent that technology that is non-destructive.
- It has been patented today, and again, I'm an economist, so I apologize.
- It's patented. Now we need to get to market.
- Are we developing that patent that way? Mr. Chair and, and Senator, I, it can vary, I think.
- And so he patented it.
CA
California 2025-2026 Regular Session
Assembly Privacy and Consumer Protection Committee Mar 18th, 2025
Transcript Highlights:
- There isn't patent prosecution and all of that happens with patents because it's slightly different.
- The Patent Office decides in advance who's patent... are companies supposed to distinguish what is copyrighted
- There isn't patent prosecution and all of that happens with patents because it's slightly different.
- The patent office decides in advance who's patent. That's sort of the difference versus a patent.
- The patent office decides in advance whose patent it is.
Summary:
The Assembly Privacy and Consumer Protection Committee met with a new membership roster and adopted its committee rules after quorum was established. The hearing then began with AB 412, the AI Copyright Transparency Act, which would require generative AI developers to provide copyright holders notice when registered copyrighted works are used in training data. The author and supporters, including SAG-AFTRA, the Transparency Coalition, voice actors, writers, labor groups, and other creators, argued the bill would give artists a practical way to learn whether their works were used and to vindicate their rights. Opponents, including EFF, CalChamber, RIAA, CCIA, Chamber of Progress, Bay Area Council, BSA, and TechNet, said the proposal was technically unworkable, could burden startups, conflict with existing law and pending litigation, and raise federal preemption concerns. Members discussed the bill’s amendments, including a fingerprinting approach and narrowing the bill to model developers, and the committee voted 8-2 to pass AB 412 as amended to the Judiciary Committee.
The committee then heard AB 446, which would prohibit “surveillance pricing,” or the use of personal data to charge different prices for the same product or service. The author and supporters, including Consumer Watchdog, UFCW, labor organizations, and consumer/privacy groups, described examples of differential pricing tied to device type, location, shopping behavior, and digital price tags, and argued the bill would protect consumers from discriminatory and predatory pricing. Business and industry opponents, including CalChamber, grocers, retailers, travel, broadband, and other associations, said the bill could conflict with the CCPA, interfere with loyalty and rewards programs, and create confusion about personalized discounts and dynamic pricing. The discussion focused on how the bill would treat loyalty programs, whether existing privacy law already covers the issue, and whether the proposal would unintentionally affect legitimate discounts and promotions.
CA
California 2025-2026 Regular Session
Assembly Select Committee on Biotechnology and Medical Technology Aug 19th, 2025
Transcript Highlights:
- And that's strong because large pharma is facing a patent cliff over the next 10 years.
- They need to replace those drugs that are going off patent with new technologies.
- A startup spun out of microbiome... on UC patents.
- Patent and Trademark Office is examining the impact of the proposed reduced F&A rate on, one, moving
- reduced budgets. ...examining patent applications under review due to reduced budgets.
Summary:
The Assembly Select Committee on Biotechnology and Medical Technology met on August 19, 2025 to examine the effects of federal grant cuts, tariff uncertainty, and related policy changes on California’s biotech, medtech, and academic research ecosystem. The chair and panelists emphasized California’s outsized role in the industry, describing major clusters in the Bay Area, Los Angeles, and San Diego, and explaining how research, startup formation, manufacturing, and clinical trials are interconnected across the state. Speakers from Biocom California, California Life Sciences, Farma, UC, Stanford, CSU Biotech, and UCLA all argued that NIH and NSF funding are foundational to discovery, workforce training, and commercialization, and that disruptions are already chilling venture capital, startup formation, and hiring.
Witnesses described several concrete impacts: suspended or terminated grants, reduced doctoral admissions, fewer training opportunities, canceled retreats and internships, and anxiety among graduate students and early-career researchers. UC reported hundreds of millions of dollars in suspended or terminated NIH and NSF funding, while Stanford said more than a thousand training and career-development grants nationwide have been frozen or ended, affecting multiple trainees per grant. CSU Biotech said 133 federal grants had been terminated, scaled back, or canceled, totaling about $140 million, including nearly $30 million from NIH and NSF. Industry representatives also warned that proposed antitrust limits on mergers and acquisitions could undermine the standard biotech exit path and further deter investment.
Committee members asked about the duration of the disruption, the possibility of state action to offset federal losses, and whether California could better support workforce development, manufacturing, and R&D tax credits. Panelists urged the Legislature to preserve and expand state support for STEM education, internships, apprenticeship pathways, manufacturing incentives, and the R&D tax credit, and to consider infrastructure and housing as part of competitiveness. They also noted that tariffs are already raising costs for medtech components and building materials, and that China is increasingly competing for R&D, talent, and licensing deals. No formal votes or bill actions were taken at the hearing; the meeting was informational and focused on testimony and discussion.
CA
California 2025-2026 Regular Session
Assembly Banking and Finance Committee Apr 28th, 2025
Transcript Highlights:
- With me today to testify is Jonathan Stroud with Unified Patents.
- My name is Jonathan Stroud, and I’m here today on behalf of Unified Patents to express our support for
- With me today to testify is Jonathan Stroud with United Patents.
- My name is Jonathan Stroud and I'm here today on behalf of Unified Patents to express our support for
- Ponzi schemes, frivolous patent litigation abuses, and attempts to avoid state-sponsored sanctions by
Summary:
The Assembly Banking and Finance Committee met to hear several bills, beginning with a consent calendar that included AB 665 and AB 866, both adopted on a do pass basis and referred to Appropriations. The committee then took up AB 801, which would create a California Community Reinvestment Act to require covered financial institutions, including state-chartered banks, credit unions, residential mortgage lenders, and money transmitters, to meet the financial needs of low- and moderate-income communities and communities of color. The author and supporters argued the bill would close gaps left by the federal CRA, address redlining and discriminatory lending, and expand investment in housing, small business, and community development. Support came from community groups, CDFIs, labor, and housing advocates, while opposition from mortgage bankers and credit unions argued the bill would impose costly new reporting and regulatory burdens, especially on institutions they said already serve underserved borrowers well. Committee members discussed the scope of the bill, the experience of other states with state CRA laws, and possible carve-outs or tiered treatment for smaller credit unions. AB 801 was passed as amended and referred to Appropriations, with the roll left open and later completed; one member voted no and others were not voting or voted aye as the roll was finalized.
The committee also heard AB 743, which would require licensing and surety bonds for commercial lawsuit financing and bring those transactions under DFPI oversight. The author said the bill was aimed at a largely unregulated, multi-billion-dollar industry and was intended to increase transparency and address concerns about foreign interests, fraud, and abusive litigation funding practices, while not affecting consumer legal funding. Supporters, including Unified Patents, the Civil Justice Association of California, the California Chamber of Commerce, the California Trucking Association, and the American Property Casualty Insurance Association, said the bill was an important first step toward disclosure and regulation. There was no opposition testimony. AB 743 passed unanimously as amended and was referred to Appropriations, with the roll held open briefly for absent members before the committee adjourned.
TX
Transcript Highlights:
- and somebody can grab the patent and not let anybody else have it?
- There are ways on both sides of that to patent the extraction process or to patent the synthesis process
- If you don't have a patent, you're given essentially the same mandate of a patent to produce.
- It is no longer patentable.
- And that's part of the challenge with the whole patent process in the FDA.
Bills:
HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246
Keywords:
HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care
Summary:
The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.
AL
Alabama 2025 Regular Session
Alabama House Education Policy Committee Apr 16th, 2025
Education Policy
Transcript Highlights:
- A pronoun or title that is patently inconsistent with the student's name, with the student's sex without
- So that's adding the word "patently". And then on line 65, basically... patently.
- strike other than the student's legal name or a derivative thereof or by and then add the word "patently
- And then add the word "patently" to patently inconsistent.
US
US Federal 2025-2026 Regular Session
Hearings to examine the nomination of Howard Lutnick, of New York, to be Secretary of Commerce. Jan 29th, 2025 at 09:15 am
Commerce, Science, and Transportation Committee
Transcript Highlights:
- It takes 21 months to get a patent pending.
- I am a patent holder. I've used the Patent Office over many years. It can be much more productive.
- They don't give us protection, and they come in and use our patent office against us.
- We need to enhance their ability to get patents.
- I think the Chinese use our patent office against us.
MN
Minnesota 2025 1st Special Session
House Higher Education Finance and Policy Committee 2/27/25
Higher Education Finance and Policy
Transcript Highlights:
- Patent, which is another one for you, Representative Allen.
- So thank you for that, Director Weber. about uh uh getting patents and uh doing about uh uh getting patents
- And another question that's come up is patents.
- One of the things we do is patent crop varietal protection, or the Patent Act at the federal level, that
- we can patent crop varieties that we develop.
TX
Transcript Highlights:
- Intellectual property is where they patent things and they patent process and drugs and things like that
- I thought insofar as the patents go, it's not the state of Texas that owns the patents.
- Right so so but we We don't own the patent, we get the royalties.
- Monsanto patented glyphosate.
- Glyphosate's first patent. patent was to inhibit the uptake of minerals on boilers like the calcium.
NM
New Mexico 2025 Regular Session
IC - Land Grant Jul 14th, 2025
House Rural Development, Land Grants And Cultural Affairs
Transcript Highlights:
- Congress set up a patent process.
- and/or for their grant of land, and that patent or that grant would then be submitted to Congress and
- And what that did was that someone would apply for a patent of land out in the middle of the frontier
- So they would get a patent for the La Union town site. site, which exists in Dona Ana County, as a way
- Land-grant, you probably have an established land-grant that may have gotten a patent of land from the
FL
Transcript Highlights:
- Over the last two years, the center has patented three new types of grapes.
- To date, we received a little over $230,000 for these patent activity fees.
- OP Solutions also supports research activities, ...for these patent activity fees.
- , including with a startup company that... ...developing patents, including with a startup company that
- There have been 60 U.S. patents, 25 of those are licensed to private sector companies who are attempting
Summary:
The Education Postsecondary Committee held its first meeting and focused on state university centers and institutes, with an overview from the Board of Governors on how the more than 500 centers and institutes across Florida’s public universities are categorized, overseen, and reported. The Board described three categories: state-level centers, legislatively established centers, and university-established centers. Members were told universities must maintain policies, notify the Board of changes, publish public inventories, and submit annual reports and compliance certifications. Senator Harrell asked about funding sources and whether underperforming centers are reviewed for elimination; the response was that funding varies by center and that universities decide whether to maintain or disband centers under their own policies, with annual reporting and audit findings shared with the Board.
Four university presentations followed. Florida Atlantic University highlighted its Center of Excellence in Biomedical and Marine Biotechnology, describing research in marine-derived drug discovery, genomics, imaging, cancer, neurodegenerative disease, and ocean sustainability, along with spin-off institutes and partnerships that have generated significant grant and contract support. FIU presented its Center of Excellence for Hurricane Damage Mitigation and Product Development, emphasizing the Wall of Wind facility, hurricane and water intrusion testing, code and product innovation, insurance modeling, and future expansion toward higher wind speeds and flood simulation. Florida State University’s High-Performance Materials Institute described work in advanced materials, aerospace composites, sensors, nanocomposites, and AI-enabled materials development, along with patents, industry partnerships, and new facilities tied to economic development. The University of Florida’s Lastinger Center for Learning outlined its work on teacher professional learning, literacy, New Worlds Reading, tutoring, and mathematics supports, including microcredentials, statewide book distribution, and early results showing improved reading confidence and growth.
Members generally praised the centers for their research, commercialization, workforce development, and education impacts. Senator Jones and Senator Harrell commended the Lastinger Center’s literacy work and the broader return on investment from these programs, while Senator Berman noted the value of the synergies across institutions. The chair emphasized that future funding requests should clearly show measurable success, commercialization, and statewide impact. The committee then adjourned without any formal votes on legislation.
CA
California 2025-2026 Regular Session
Assembly Health Committee Jun 16th, 2026
Transcript Highlights:
- Department of Health and Human Services... ...would be able to, because the manufacturers currently have a patent
- Once the patent, you know this better than I do, once the patent would expire...
- Department of Health and Human Services would be able to, because the manufacturers currently have a patent
- Once the patent, you know this better than I do.
- Once the patent would expire, Once the patent, you know this better than I do, once the patent would
Summary:
The Assembly Health Committee heard several bills focused on mental health access, preventive care, health care costs, detention oversight, and daylight saving time. SB 989 would streamline Care Court referrals by allowing first responders to ask county behavioral health agencies to review and file petitions; supporters, especially firefighters and families, said the current process is too burdensome, while Disability Rights California and other opponents argued Care Court is coercive and unproven. SB 1089, as amended, would direct CalRx/HHS to help distribute GLP-1 medications more broadly and more affordably; the author described her own experience with the drugs, and the bill drew support from medical and life sciences groups with no opposition. SB 1309 would eliminate out-of-pocket costs for medically appropriate lung cancer screening follow-up care; cancer advocates and survivors strongly supported it, while health plans and insurers opposed it as costly and said the bigger problem is low initial screening rates. The committee also heard SB 1284, which would require DHCS to report large employers whose workers are enrolled in Medi-Cal and estimate taxpayer costs, framed by supporters as a transparency measure about corporate reliance on public coverage. SCR 7, urging permanent standard time for health reasons, passed with support from medical groups and no opposition. SB 995, the Masuma Khan Justice Act, would create statewide inspection and enforcement standards for large involuntary residential facilities, including private immigration detention centers and certain youth facilities; supporters cited unsafe and inhumane conditions, while county probation officials objected to duplicative oversight for secure youth treatment facilities. The committee took votes on each measure, and the bills and resolution advanced, with SB 1309 and SB 1284 moving on amended and the others also reported out; the consent calendar was approved as well.
CA
California 2025-2026 Regular Session
Assembly Banking and Finance Committee Apr 28th, 2025
Banking and Finance
Transcript Highlights:
- Today to testify is Jonathan Stroud with Unified Patents.
- I'm here today on behalf of Unified Patents to express our support for AB 743.
- Unified Patents is a broad-based membership organization with hundreds of members from all parts of the
- lawsuits and abuse by offering reliable public information, filing public challenges, and improving patent
- Ponzi schemes, frivolous patent litigation abuses, and attempts to avoid state-sponsored sanctions by
MN
Minnesota 2025 1st Special Session
Working Group on Omnibus Jobs, Labor and Economic Development - 05/27/25
Minnesota Senate Floor Meeting
Transcript Highlights:
- I am a patent agent registered to practice before the U.S. Patent and Trademark Office.
- and dozens of foreign patents.
- In that capacity, I manage the patents In that capacity, I manage the patents and<00:07:45.199><
- While patent and trade secret today.
- <00:08:48.800>
when makes the effort to patent when makes the effort to patent when appropriate
MN
Transcript Highlights:
- million in revenue each year from licensing and patenting.
- million in revenue each year from licensing and patenting.
- million in revenue each year from licensing and patenting.
- million in revenue each year from licensing and patenting.
- million in revenue each year from licensing and patenting.